All Stories

  1. Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study
  2. LOCALIZE SCROTAL KAPOSI SARCOMA IN A HIV-NEGATIVE PATIENT
  3. Prognostic value of IMDC score in non-small cell lung cancer receiving immunotherapy: old dog, new tricks?
  4. The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study
  5. Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy
  6. Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
  7. BEFORE & AFTER: THE EVALUATION OF THE EFFECT OF THE COVID-19 PANDEMIC ON CANCER PATIENTS IN PALLIATIVE CARE CENTER
  8. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)
  9. The Utility of the Cachexia Index and the Modified Glasgow Score in Young Patients With Breast Cancer
  10. Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study
  11. Cancer Care After the Earthquake? What Is Left to Us?
  12. The correlation between pre-treatment CEA levels and the EGFR mutation status in advanced lung adenocarcinoma
  13. After an Earthquake: The Comparison of Psychological Status of Resident and Earthquake Survivor Cancer Patients
  14. Laboratory Parameters Predicting Brain Metastasis in Patients with Lung Cancer
  15. The efficacy of IMDC score in Malignant Melanoma
  16. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
  17. Kanser hastalarında aşılanma durumu ve aşılanmayı etkileyen faktörlerin değerlendirilmesi
  18. Three Perspectives: The Approach of Neoadjuvant Treatment of Rectum Cancer According to Medical Oncologists, Radiation Oncologists, and Surgeons
  19. A New Prognostic Index in Young Breast Cancer Patients
  20. Microsatellite instability (MSI) in endometrial cancer; frequency and prognostic significance
  21. The Effect of COVID-19 on Radiation Oncology Practice in Türkiye
  22. Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study
  23. The Effect of The Body Composition to Prognosis in Young Breast Cancer Patients
  24. Prognostic Value of Systemic Immune Index in Patients with Metastatic Gastric Cancer
  25. Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience
  26. The effect of body composition on prognosis in critically ill COVID-19 patients
  27. Investigation of the Effect of Tumor Location in Patients with Stage III Colon Cancer Receiving Adjuvant Oxaliplatine-Based Adjuvant Chemotherapy
  28. The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer
  29. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients
  30. Intravenous Chemotherapy Adherence of Cancer Patients in Time of Covid-19 Crisis
  31. The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study
  32. Adjuvant chemotherapy in gastric cancer
  33. The Effect of The Body Composition to Prognosis in Young Breast Cancer Patients
  34. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial
  35. The Comparison of Central Venous Port Catheters in Gastrointestinal Cancer Treatment
  36. The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer
  37. P1.14-15 Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
  38. The compliance with antiemetic guidelines of Turkish medical oncologists. A survey study of Turkish Oncology Group
  39. Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study
  40. Are preoperative serum CA15-3 levels different in breast cancer subgroups?
  41. Does Vitamin D Replacement Alter the Chemotherapy Outcome in Lung Cancer
  42. Is TTF-1 a prognostic marker in non-small cell lung adenokarsinoma?
  43. Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naïve breast cancer: real-life practice outcomes
  44. Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy. A multicenter, prospective, and observational study
  45. Efficiency and safety of regorafenib in metastatic colorectal cancer (mCRC): Real life experience from Turkey.
  46. Cetuximab Treatment for Head and Neck Skin Cancer in a Patient with Heart Transplantation
  47. The Relationship Between the Level of Parathormone and the Existence and the Degree of Coronary Atherosclerosis
  48. Oxaliplatin induced acute immune-mediated thrombocytopenia; a case report